Company / PP&E per Share
NEKTAR THERAPEUTICS PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.17
FY2025
5-year range
$0.02 / $0.34
FY2021-FY2025
Trend
+833.2%
vs FY2024
Sector context
#89 of 191
Health Care
What the data says
PP&E per Share changed +833% YoY in FY2025, a notable deviation from the 9-year average annual change of +71%.
Based on SEC 10-K filings.
0.17 in FY2025 with a 5-year CAGR of -13.2%.
Improved from $0.10 to $0.17 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -1.7%
- 5-Year CAGR
- -13.2%
- 10-Year CAGR
- -
Sector benchmark
#89 of 191 in Health CareTop 47% of 191This company $0.17 Sector average $18.90
▼
-99.1% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 833.2% year-over-year.
- Ranks #89 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2016.
- Lowest pp&e per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.17 | +833.2% |
| FY2024 | $0.02 | -82.2% |
| FY2023 | $0.10 | -42.8% |
| FY2022 | $0.17 | -47.9% |
| FY2021 | $0.34 | -0.6% |
| FY2020 | $0.34 | -9.8% |
| FY2019 | $0.37 | +22.3% |
| FY2018 | $0.31 | -1.1% |
| FY2017 | $0.31 | -36.1% |
| FY2016 | $0.48 | -10.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026